Covered recipient · General Payments record
MICHAEL EDWARD RINKER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$517.15
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $324.84 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $60.77 | 4 |
| Lilly USA, LLC | $50.55 | 3 |
| Novo Nordisk AS | $35.78 | 2 |
| Acerta Pharma LLC | $33.12 | 2 |
| Merck Sharp & Dohme Corporation | $27.66 | 1 |
| DEXCOM, INC. | $23.32 | 1 |
| Lundbeck LLC | $21.74 | 1 |
| Amgen Inc. | $20.39 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $20.04 | 1 |
| GlaxoSmithKline, LLC. | $17.06 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.39 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117365145 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.97 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105734215 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.15 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104312598 | CMS |
| Boston Scientific Corporation | $20.04 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092343718 | CMS |
| Dexcom, Inc. | $23.32 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153322888 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.41 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101322348 | CMS |
| GlaxoSmithKline, LLC. | $17.06 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116039991 | CMS |
| Lilly USA, LLC | $20.77 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135232533 | CMS |
| Lilly USA, LLC | $15.19 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135232538 | CMS |
| Lilly USA, LLC | $14.59 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135172286 | CMS |
| Lundbeck LLC | $21.74 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145961508 | CMS |
| Merck Sharp & Dohme LLC | $27.66 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141598404 | CMS |
| Novo Nordisk Inc | $17.18 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097798163 | CMS |
| Novo Nordisk Inc | $18.60 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096615204 | CMS |
| PFIZER INC. | $13.14 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131481296 | CMS |
| PFIZER INC. | $17.48 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131980193 | CMS |
| PFIZER INC. | $16.18 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131054126 | CMS |
| PFIZER INC. | $13.97 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131047729 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.